Tag : OverAllotment

Latest News

Advaxis, Inc. Announces Closing of $17 Million Public Offering and Exercise in Full of the Underwriters’ Over-Allotment Option

PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced the...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy